Effective January 1, AATB transitioned from a 501(c)(3) nonprofit membership association to a 501(c)(6) trade association and now operates as the Association for Advancing Tissue and Biologics (AATB).

On Wednesday, December 24, the Centers for Medicare and Medicaid Services (CMS) announced the withdrawal of the final Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs).

AATB is pleased to announce the release of an updated version of the Sepsis Pilot Study Report, originally published in September 2024.

AATB members have voted to approve the proposal to repeal and replace the AATB Bylaws.

AATB is excited to invite all AATB members to participate in our Capitol Hill Fly-In on February 25, 2026.

We’re excited to share a new way to engage with the topics that matter most to our community.

Blood Centers of America (BCA) helps AATB member establishments save through its extensive suppli

We are excited to announce that, following a rigorous review and evaluation by the STAC Grant Subcommittee, two proposals have been selected as this year’s AATB Grant Program recipients.

AATB is pleased to announce the incoming 2025-2027 Officers and At-Large members of the Board of Governors.